Literature DB >> 24680006

New insights on keloids, hypertrophic scars, and striae.

Sara Ud-Din1, Ardeshir Bayat2.   

Abstract

This article presents an overview of the literature regarding treatments for keloid disease, hypertrophic scars, and striae distensae in dark pigmented skin. Striae, keloid, and hypertrophic scarring present a challenging problem for both the clinician and patient. No single therapy is advocated for hypertrophic scars, keloid scars, or striae distensae. New therapies have shown promise in the treatment of hypertrophic and keloid scars, and in patients with dark pigmented skin. This article provides guidance on the assessment and determination of patients' suitability for certain treatment options, as well as advice on the follow-up of patients affected with problematic scarring and striae.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assessment; Focused treatment options; Hypertrophic scars; Keloid disease; Prevention; Striae distensae; Treatment

Mesh:

Substances:

Year:  2014        PMID: 24680006     DOI: 10.1016/j.det.2013.11.002

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  22 in total

Review 1.  microRNA deregulation in keloids: an opportunity for clinical intervention?

Authors:  Xin Yu; Zheng Li; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-10-21       Impact factor: 6.831

2.  On the diagnosis and treatment of cutaneous and soft tissue tumours misdiagnosed as scars: Lessons from four cases.

Authors:  Yinmin Wang; Feng Yang; Xiao L Wu; Fei Liu; Rui Jin; Chuan Gu; Tao Ni; Xi Wang; Qun Yang; Xusong Luo; Jun Yang
Journal:  Int Wound J       Date:  2019-02-15       Impact factor: 3.315

3.  Treatment of ear keloids: algorithm for a multimodal therapy regimen.

Authors:  Julia Thierauf; M Walther; N Rotter; M-O Scheithauer; T K Hoffmann; J A Veit
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-08-20       Impact factor: 2.503

4.  HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways.

Authors:  Rui Lei; Jian Li; Feng Liu; Weihan Li; Shizhen Zhang; Yang Wang; Xi Chu; Jinghong Xu
Journal:  Cell Cycle       Date:  2019-10-23       Impact factor: 4.534

5.  Fractionated CO2 Laser in the Treatment of Striae Alba in Darker Skinned Patients - A Prospective Study.

Authors:  Zohreh Tehranchinia; Alireza Mahboubianfar; Hoda Rahimi; Nazanin Saedi
Journal:  J Lasers Med Sci       Date:  2017-12-26

6.  Compression therapy affects collagen type balance in hypertrophic scar.

Authors:  Shawn Tejiram; Jenny Zhang; Taryn E Travis; Bonnie C Carney; Abdulnaser Alkhalil; Lauren T Moffatt; Laura S Johnson; Jeffrey W Shupp
Journal:  J Surg Res       Date:  2015-11-05       Impact factor: 2.192

7.  Pentoxifylline for the Prevention of Postsurgical Keloid Recurrence.

Authors:  Andrea Tan; Orlando Martinez Luna; Donald A Glass
Journal:  Dermatol Surg       Date:  2020-10       Impact factor: 2.914

8.  A Translational Animal Model for Scar Compression Therapy Using an Automated Pressure Delivery System.

Authors:  A Alkhalil; S Tejiram; T E Travis; N J Prindeze; B C Carney; L T Moffatt; L S Johnson; J Ramella-Roman; J W Shupp
Journal:  Eplasty       Date:  2015-07-02

9.  GLUT-1 Enhances Glycolysis, Oxidative Stress, and Fibroblast Proliferation in Keloid.

Authors:  Ying-Yi Lu; Chieh-Hsin Wu; Chien-Hui Hong; Kee-Lung Chang; Chih-Hung Lee
Journal:  Life (Basel)       Date:  2021-05-30

10.  Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression.

Authors:  Jing Li; Zhiyu Li; Song Wang; Jianhai Bi; Ran Huo
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.